J&J invests in “cell-free” cartilage repair technology

JNJ LEADS $15 MILLION FUNDING FOR INNOVATIVE CARTILAGE TECHNOLOGY (Orthopedics This Week) website.. http://www.cartiheal.com/ Johnson & Johnson Innovation (JJDC investors) joins a blue chip list of venture investors including Elron, Accelmed, Access Medical Ventures, and Peregrine Ventures to fund an innovative cartilage repair technology called Agili-C and a promising young Israeli company named CartiHeal, Ltd. Agili-C, the technology that has attracted these top venture investors, is a calcium carbonite and HA (hyaluronic acid) implant that has been shown in several post-marketing studie...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top